| Accession Number | 0001193125-26-296296 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 6, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Jul 1, 2026 | Exercise/Conversion | 25,000 | $8.27 | $206,750.00 | 34,755 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Jul 1, 2026 | Sale | 11,024 | $87.33 | $962,779.94 | 23,731 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Jul 1, 2026 | Sale | 2,801 | $88.51 | $247,924.07 | 20,930 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Jul 1, 2026 | Sale | 11,175 | $89.31 | $998,032.54 | 9,755 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Stock option (right to buy) | Derivative | Jul 1, 2026 | Exercise/Conversion | 25,000 | $0.00 | $0.00 | 116,986 | Direct | โ | View Details |